Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism EphA3 inhibitors(Ephrin type-A receptor 3 inhibitors), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H39ClN2O8 |
InChIKeyJEHVPKICFUKWBN-TUOGILRCSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | - | - |